Doxorubicinol 13CD3-TFA - Request Quote
Doxorubicinol 13CD3-TFA
| SZ CAT No: | SZ-D081D01 |
| CAS No | NA |
| Mol.F. | C2613CH28D3NO11 : C2HF3O2 |
| Mol.Wt. | 549.6 : 114.0 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Doxorubicinol 13CD3-TFA is chemically (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-((S)-1,2-dihydroxyethyl)-6,8,11-trihydroxy-1-(methoxy-13C-d3)-7,8,9,10-tetrahydrotetracene-5,12-dione 2,2,2-trifluoroacetate. Doxorubicinol 13CD3-TFA is supplied with detailed characterization data compliant with regulatory guideline. Doxorubicinol 13CD3-TFA can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Doxorubicinol.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Doxorubicinol 13CD3-TFA
Purchase Doxorubicinol 13CD3-TFA
Doxorubicinol 13CD3-TFA suppliers
Doxorubicinol 13CD3-TFA manufacturers
Doxorubicinol 13CD3-TFA price
Order Doxorubicinol 13CD3-TFA
Enquire Doxorubicinol 13CD3-TFA
Doxorubicinol 13CD3-TFA cost
Doxorubicinol 13CD3-TFA Supplier
Doxorubicinol 13CD3-TFA Distributor
Doxorubicinol 13CD3-TFA for Method Validation
Doxorubicinol Reference Standard
Doxorubicinol 13CD3-TFA for ANDA Filing
Doxorubicinol 13CD3-TFA for Forced Degradation Studies
Doxorubicinol 13CD3-TFA Identification Standards
Doxorubicinol 13CD3-TFA for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.